文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛心脑血管急症

脓毒症存活者与长期心血管结局的关联:系统评价与荟萃分析

Association between sepsis survivorship and long-term cardiovascular outcomes in adults: a systematic review and meta-analysis.
PubMed 文献 · Intensive Care Med · 2021-08-09
一句话结论脓毒症存活者出院后长期心梗、卒中、心衰风险显著升高,风险至少持续5年,需长期心血管随访。

该系统评价与荟萃分析纳入27项观察性研究(25项队列、2项病例交叉),评估成人脓毒症存活者长期心血管结局。脓毒症存活者心梗、卒中、心衰的汇总累积发生率在最长随访时为3%–9%。与非脓毒症对照相比,脓毒症存活者长期心梗风险aHR 1.77(95%CI 1.26–2.48;低确定性)、卒中aHR 1.67(95%CI 1.37–2.05;低确定性)、充血性心衰aHR 1.65(95%CI 1.46–1.86;极低确定性)均显著升高。提示脓毒症存活者出院后存在长期超额心血管风险,至少持续5年,临床应重视长期心血管随访。

要点

  • 脓毒症存活者长期心梗风险升高:aHR 1.77(95%CI 1.26–2.48),证据确定性低。
  • 脓毒症存活者长期卒中风险升高:aHR 1.67(95%CI 1.37–2.05),证据确定性低。
  • 脓毒症存活者长期充血性心衰风险升高:aHR 1.65(95%CI 1.46–1.86),证据确定性极低。
  • 心梗、卒中、心衰的汇总累积发生率在最长随访时为3%–9%。
  • 超额风险至少持续至出院后5年以上,出院后应纳入长期心血管风险评估与随访。

适用人群与场景

  • 成人脓毒症存活者(出院后),对照为非脓毒症住院存活者或一般人群对照。
  • 研究场景为出院后长期随访,最长随访从30天至超过5年。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:系统评价与荟萃分析,纳入27项观察性研究(25项队列研究、2项病例交叉研究)。
  • 样本量:每项研究中脓毒症存活者中位数4,289(IQR 502–68,125),对照中位数18,399(IQR 4,028–83,506)。
  • 主要终点:与非脓毒症对照相比,脓毒症存活者长期心梗aHR 1.77(95%CI 1.26–2.48;低确定性)、卒中aHR 1.67(95%CI 1.37–2.05;低确定性)、充血性心衰aHR 1.65(95%CI 1.46–1.86;极低确定性)。
  • 脓毒症存活者心梗、卒中、心衰的汇总累积发生率在最长随访时为3%–9%。
  • 超额风险至少持续至出院后5年以上。

证据类型、等级与局限

  • 证据类型:观察性研究的系统评价与荟萃分析(25项队列研究、2项病例交叉研究)。
  • 证据确定性:心梗低确定性、卒中低确定性、充血性心衰极低确定性(原文GRADE分级)。
  • 局限:纳入研究均为观察性设计,存在混杂可能;原文未提及更多局限。

对床旁实践的改变

  • 脓毒症存活者出院后应视为长期心血管高风险人群,至少5年内需关注心梗、卒中、心衰风险。
  • 原文未提供具体筛查或干预方案,临床决策需结合个体情况。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

PURPOSE: We aimed to determine the association between sepsis and long-term cardiovascular events.

METHODS: We conducted a systematic review of observational studies evaluating post-sepsis cardiovascular outcomes in adult sepsis survivors. MEDLINE, Embase, and the Cochrane Controlled Trials Register and Database of Systematic Reviews were searched from inception until April 21st, 2021. Two reviewers independently extracted individual study data and evaluated risk of bias. Random-effects models estimated the pooled crude cumulative incidence and adjusted hazard ratios (aHRs) of cardiovascular events compared to either non-septic hospital survivors or population controls. Primary outcomes included myocardial infarction, stroke, and congestive heart failure; outcomes were analysed at maximum reported follow-up (from 30 days to beyond 5 years post-discharge).

RESULTS: Of 12,649 screened citations, 27 studies (25 cohort studies, 2 case-crossover studies) were included with a median of 4,289 (IQR 502-68,125) sepsis survivors and 18,399 (IQR 4,028-83,506) controls per study. The pooled cumulative incidence of myocardial infarction, stroke, and heart failure in sepsis survivors ranged from 3 to 9% at longest reported follow-up. Sepsis was associated with a higher long-term risk of myocardial infarction (aHR 1.77 [95% CI 1.26 to 2.48]; low certainty), stroke (aHR 1.67 [95% CI 1.37 to 2.05]; low certainty), and congestive heart failure (aHR 1.65 [95% CI 1.46 to 1.86]; very low certainty) compared to non-sepsis controls.

CONCLUSIONS: Surviving sepsis may be associated with a long-term, excess hazard of late cardiovascular events which may persist for at least 5 years following hospital discharge.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Kosyakovsky LB, Angriman F, Katz E, et al. Association between sepsis survivorship and long-term cardiovascular outcomes in adults: a systematic review and meta-analysis. Intensive Care Med. 2021. PMID: 34373953. doi:10.1007/s00134-021-06479-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。